beta

CLBS

Caladrius Biosciences, Inc.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes CLBS12, CLBS14, CLBS16, and CLBS03. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ.

Market Cap: 28.8 Million

Primary Exchange: NASDAQ

Website: http://www.caladrius.com

Shares Outstanding: 14.9 Million

Float: 14.4 Million

Dividend: (%)

Beta: 0.202369083375244

Sector: Distribution Services

Industry: Wholesale Distributors

Ethical Flags

Longest drawdown: 1807 trading days

From: 2013-09-19 To: 2020-06-02

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2016-07-28 10.0 1.0 10.0
2013-07-16 10.0 1.0 10.0
Data provided by IEX Cloud